The Effect of Insulin Treatment on Rac1 Expression in Diabetic Kidney

被引:5
|
作者
Gumustekin, Mukaddes [1 ]
Micili, Serap Cilaker [2 ]
Arici, Mualla Aylin [1 ]
Karaman, Meral [3 ]
Guneli, Mehmet Ensari [3 ]
Tekmen, Isil [2 ]
机构
[1] Dokuz Eylul Univ, Sch Med, Dept Pharmacol, Izmir, Turkey
[2] Dokuz Eylul Univ, Sch Med, Dept Histol & Embryol, Izmir, Turkey
[3] Dokuz Eylul Univ, Sch Med, Dept Lab Anim Sci, Izmir, Turkey
关键词
apoptosis; caspase-3; diabetic nephropathy; insulin; Rac1; TUBULAR EPITHELIAL-CELLS; NADPH OXIDASE; OXIDATIVE STRESS; APOPTOSIS; MELATONIN; NEPHROPATHY; PROTECTS; GLUCOSE; GTPASE; DAMAGE;
D O I
10.3109/0886022X.2013.764256
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
This study was designed to evaluate the renoprotective effect of insulin on diabetic nephropathy through Rac1 inhibition. Twenty Wistar rats were divided into three groups: control (C), diabetic (D), and insulin-treated diabetic (D + I). Diabetes was induced by a single streptozotocin (STZ) injection (45 mg/kg i.p.) in adult male rats. Diabetic animals were treated subcutaneously with insulin (6 U/kg), or saline once a day for 8 weeks. Age-matched control rats received only saline. The kidney tissue samples were analyzed by immunohistochemical staining for Rac1 and cleaved caspase-3 expressions and using the TUNEL method for determining apoptotic cells. Diabetes increased the number of TUNEL (+) cells and cleaved caspase-3 and Rac1 expression levels in kidney. Administration of insulin for 8 weeks reduced Rac1 expression and ameliorated histopathological changes in kidney of STZ-induced diabetes model. These results may suggest that the renoprotective effect of insulin at least partly results from inhibition of Rac1 overexpression.
引用
收藏
页码:396 / 402
页数:7
相关论文
共 50 条
  • [1] RAC1 INHIBITION FOR THE TREATMENT OF MEDULLOBLASTOMA
    Ayad, Nagi
    Jangde, Nitish
    NEURO-ONCOLOGY, 2024, 26
  • [2] Identification and association of RAC1 gene polymorphisms with mRNA and protein expression levels of Rac1 in solid organ (kidney, liver, heart) transplant recipients
    Zhou, Jiali
    Liu, Yani
    Luo, Xiaomei
    Shen, Rufei
    Yang, Chunxiao
    Yang, Tingyu
    Shi, Shaojun
    MOLECULAR MEDICINE REPORTS, 2016, 14 (02) : 1379 - 1388
  • [3] Local Mineralocorticoid Receptor Activation and the Role of Rac1 in Obesity-Related Diabetic Kidney Disease
    Yoshida, Shigetaka
    Ishizawa, Kenichi
    Ayuzawa, Nobuhiro
    Ueda, Kohei
    Takeuchi, Maki
    Kawarazaki, Wakako
    Fujita, Toshiro
    Nagase, Miki
    NEPHRON EXPERIMENTAL NEPHROLOGY, 2014, 126 (01): : 16 - 24
  • [4] Effect of blocking Rac1 expression in cholangiocarcinoma QBC939 cells
    Liu, Xudong
    Wang, Guangyi
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2011, 44 (05) : 483 - 488
  • [5] Targeting RAC1 might be a potential therapeutic strategy for diabetic kidney disease: a Mendelian randomization study
    Han, Shisheng
    Jia, Meng
    Yao, Tianwen
    Xu, Yanqiu
    Wang, Yi
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, : 625 - 633
  • [6] Diabetic Retinopathy: Regulation of Ceramide Production and Rac1 Activation
    Alka, Kumari
    Kowluru, Renu A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [7] Photoreceptor degeneration induces an increase in Rac1 expression
    Hamassaki-Britto, D
    Belmonte, MA
    Castro, LM
    Santos, MF
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U179 - U179
  • [8] RAC1 and Melanoma
    Halaban, Ruth
    CLINICAL THERAPEUTICS, 2015, 37 (03) : 682 - 685
  • [9] Trapping Rac1
    Karin Kuehnel
    Nature Chemical Biology, 2018, 14 (1) : 1 - 1
  • [10] Single-Cell RNA Sequencing Reveals RAC1 Involvement in Macrophages Efferocytosis in Diabetic Kidney Disease
    Song, Yi
    Liu, Yifan
    Guo, Feng
    Zhao, Lin
    Qin, Guijun
    INFLAMMATION, 2024, 47 (02) : 753 - 770